| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) |
|---|---|---|---|
| AstraZeneca | Alexion Pharmaceuticals | 12 Dec 2020 | 39,000.0 |
| Gilead Sciences | Immunomedics | 13 Sep 2020 | 21,000.0 |
| Thermo Fisher Scientific | PPD | 15 Apr 2021 | 20,900.0 |
| Siemens Healthineers | Varian Medical Systems | 02 Aug 2020 | 16,400.0 |
| Soaring Eagle Acquisition | Ginkgo BioWorks | 11 May 2021 | 15,000.0 |
| Bristol-Myers Squibb | MyoKardia | 05 Oct 2020 | 13,100.0 |
| Thermo Fisher Scientific | Qiagen | 13 Aug 2020 | 12,500.0 |
| ICON | PRA Health Sciences | 24 Feb 2021 | 12,000.0 |
| Jazz Pharmaceuticals | GW Pharmaceuticals | 03 Feb 2021 | 7,200.0 |
| Johnson & Johnson | Momenta Pharmaceuticals | 19 Aug 2020 | 6,500.0 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 9 |
| Morgan Stanley | 2 | 1 |
| Bank of America Corp | 3 | 10 |
| The Goldman Sachs Group | 4 | 4 |
| JPMorgan Chase & Co | 5 | 14 |
| Evercore | 6 | 3 |
| Lazard | 7 | 18 |
| Ondra | 8 | 67 |
| J.P. Morgan Securities | 9 | 2 |
| Cowen & Company, . | 10 | N/A |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Jefferies | 1 | 8 |
| The Goldman Sachs Group | 2 | 2 |
| Cowen | 3 | 32 |
| Centerview Partners | 4 | 4 |
| Bank of America Corp | 5 | 9 |
| SVB Financial Group | 6 | 12 |
| Morgan Stanley | 7 | 1 |
| Rothschild & Co SCA | 8 | 5 |
| Evercore | 9 | 7 |
| Barclays Plc | 10 | 23 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Wachtell, Lipton, Rosen & Katz | 1 | 3 |
| Fried, Frank, Harris, Shriver & Jacobson | 2 | 19 |
| Goodwin Procter | 3 | 20 |
| Freshfields Bruckhaus Deringer | 4 | 16 |
| Allen & Overy | 5 | 62 |
| Latham & Watkins | 6 | 21 |
| Simmons & Simmons | 7 | 172 |
| Sullivan & Cromwell | 8 | 15 |
| Davis Polk & Wardwell | 9 | 2 |
| Cravath, Swaine & Moore | 10 | 18 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Goodwin Procter | 1 | 2 |
| Wilson Sonsini Goodrich & Rosati | 2 | 22 |
| Latham & Watkins | 3 | 1 |
| Cooley | 4 | 5 |
| Ropes & Gray | 5 | 7 |
| Baker & McKenzie | 6 | 12 |
| Kirkland & Ellis | 7 | 4 |
| Morgan, Lewis & Bockius | 8 | 23 |
| Jones Day | 9 | 3 |
| Dechert | 10 | 54 |
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | AstraZeneca | Alexion Pharmaceuticals | 12 Dec 2020 | 39,000.0 | Gilead Sciences | Immunomedics | 13 Sep 2020 | 21,000.0 | Thermo Fisher Scientific | PPD | 15 Apr 2021 | 20,900.0 | Siemens Healthineers | Varian Medical Systems | 02 Aug 2020 | 16,400.0 | Soaring Eagle Acquisition | Ginkgo BioWorks | 11 May 2021 | 15,000.0 | Bristol-Myers Squibb | MyoKardia | 05 Oct 2020 | 13,100.0 | Thermo Fisher Scientific | Qiagen | 13 Aug 2020 | 12,500.0 | ICON | PRA Health Sciences | 24 Feb 2021 | 12,000.0 | Jazz Pharmaceuticals | GW Pharmaceuticals | 03 Feb 2021 | 7,200.0 | Johnson & Johnson | Momenta Pharmaceuticals | 19 Aug 2020 | 6,500.0 |
|---|
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 9 |
| Morgan Stanley | 2 | 1 |
| Bank of America Corp | 3 | 12 |
| The Goldman Sachs Group | 4 | 4 |
| JPMorgan Chase & Co | 5 | 13 |
| Evercore | 6 | 3 |
| Lazard | 7 | 15 |
| Ondra | 8 | 49 |
| Cowen & Company, . | 9 | N/A |
| Mizuho Financial Group | 10 | N/A |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 4 |
| The Goldman Sachs Group | 2 | 3 |
| Bank of America Corp | 3 | 6 |
| Jefferies | 4 | 5 |
| Lazard | 5 | 2 |
| Morgan Stanley | 6 | 1 |
| JPMorgan Chase & Co | 7 | 17 |
| Evercore | 8 | 8 |
| Barclays Plc | 9 | 23 |
| Stifel Financial Corp | 10 | 48 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Wachtell, Lipton, Rosen & Katz | 1 | 3 |
| Fried, Frank, Harris, Shriver & Jacobson | 2 | 18 |
| Goodwin Procter | 3 | 19 |
| Freshfields Bruckhaus Deringer | 4 | 20 |
| Allen & Overy | 5 | 65 |
| Simmons & Simmons | 6 | 126 |
| Sullivan & Cromwell | 7 | 15 |
| Latham & Watkins | 8 | 22 |
| Davis Polk & Wardwell | 9 | 2 |
| Cravath, Swaine & Moore | 10 | 17 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Goodwin Procter | 1 | 1 |
| Cooley | 2 | 3 |
| Morgan, Lewis & Bockius | 3 | 12 |
| Latham & Watkins | 4 | 2 |
| Wilson Sonsini Goodrich & Rosati | 5 | 16 |
| White & Case | 6 | 23 |
| Skadden, Arps, Slate, Meagher & Flom & Affiliates | 7 | 4 |
| Ropes & Gray | 8 | 15 |
| Gibson, Dunn & Crutcher | 9 | 22 |
| Kirkland & Ellis | 10 | 6 |
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | Permira Advisers | LivaNova | 04 Mar 2021 | 3,700.0 | EQT IX Fund | Recipharm | 14 Dec 2020 | 2,116.9 | Nordic Capital | Advanz Pharma | 27 Jan 2021 | 1,920.1 | Permira | neuraxpharm Arzneimittel | 22 Sep 2020 | 1,877.5 | Altaris Capital Partners | Generic Rx Pharma Business | 01 Mar 2021 | 1,550.0 | Pamplona Capital Management , Triton Investment Management Limited, CVC Capital Partners SICAV-FIS SA, Bain Capital , BC Partners | Mediq | 21 Oct 2020 | 1,416.3 | Rock Springs Capital Management , Casdin Capital | Exact Sciences | 27 Oct 2020 | 869.2 | TPG Sixth Street Partners, Columbia Threadneedle Investments, First Light Asset Management, , Rock Springs Capital Management , Silver Lake Management , Millennium Management , Eaton Vance Corp, Orbimed Advisors , ClearBridge Investments, , Tudor Investment Corporation, Coatue Management , Pura Vida Investments , T Rowe Price Associates , Fidelity Management & Research Company, Highland Capital Management, L.P, Canada Pension Plan Investment Board | Caris Life Sciences | 11 May 2021 | 830.0 | China Resources Capital Management | Boya Bio-pharmaceutical Group | 07 Sep 2020 | 818.3 | Abu Dhabi Developmental Holding | Amoun Pharmaceutical | 31 Mar 2021 | 740.0 |
|---|
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Rothschild & Co SCA | 1 | 1 |
| Deloitte Touche Tohmatsu | 2 | 23 |
| Carnegie Holding AB | 3 | N/A |
| Goldman Sachs International | 4 | N/A |
| Jefferies International | 5 | N/A |
| Ernst & Young Global | 6 | 31 |
| PricewaterhouseCoopers International | 7 | 2 |
| UBS Group AG | 8 | 3 |
| Jefferies | 9 | 48 |
| Evercore | 10 | 15 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Jefferies | 1 | 49 |
| SVB Financial Group | 2 | 35 |
| Rothschild & Co SCA | 3 | 2 |
| Carnegie Holding AB | 4 | N/A |
| Cowen | 5 | N/A |
| Deloitte Touche Tohmatsu | 6 | 7 |
| Evercore | 7 | 6 |
| Barclays Plc | 8 | 14 |
| Ernst & Young Global | 9 | 9 |
| Van Lanschot Kempen N.V. | 10 | N/A |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Ropes & Gray | 1 | 17 |
| Latham & Watkins | 2 | 10 |
| Uria Menendez Abogados S | 3 | N/A |
| Goodwin Procter | 4 | 28 |
| Clifford Chance | 5 | 41 |
| Roschier Attorneys | 6 | 38 |
| Setterwalls Advokatbyra AB | 7 | N/A |
| Allen & Overy | 8 | 53 |
| Linklaters | 9 | 5 |
| Ashurst | 10 | 7 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Latham & Watkins | 1 | 1 |
| Goodwin Procter | 2 | 35 |
| Ropes & Gray | 3 | 3 |
| Uria Menendez Abogados S | 4 | N/A |
| Baker & McKenzie | 5 | N/A |
| Kirkland & Ellis | 6 | 2 |
| DLA Piper | 7 | N/A |
| Dechert | 8 | 34 |
| Paul, Weiss, Rifkind, Wharton & Garrison | 9 | 16 |
| Wilmer Cutler Pickering Hale and Dorr | 10 | 37 |
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | FutureX Capital, Qingdao Guoxin Financial Holding , Shenzhen Fu Rong lusive Finance , Hillhouse Capital Group | Kangfeng Biotechnology (Shanghai) | 22 Feb 2021 | 1,078.9 | GV Management , New Enterprise Associates , 8VC, ARCH Venture Partners | National Resilience | 23 Nov 2020 | 750.0 | Itochu Technology Ventures, ., Emerson Collective , Invus Group , Vertex Ventures HC, EcoR1 Capital , F2 Ventures Limited, Matrix Capital Management Fund , Surveyor Capital , SoftBank Vision Fund , Redmile Group , EDBI Pte , Fidelity Management & Research Company, Samsara BioCapital , MPM Capital | ElevateBio | 15 Mar 2021 | 525.0 | Andreessen Horowitz , Nextech Invest , Casdin Capital , ARCH Venture Partners , Section 32, Arboretum Ventures , GV Management | EQRx | 11 Jan 2021 | 500.0 | General Catalyst Partners , FirstMark Capital , Dragoneer Investment Group , BoxGroup, SignalFire Management Services, , Torch Capital, TQ Ventures , Altimeter Capital Management , Baupost Group, 776 Fund Management, ShawSpring Partners, , Radcliff Group | Ro-co | 23 Mar 2021 | 500.0 | Temasek Holdings (Private) , Two Sigma Ventures , GV Management , Alexandria Venture Investments, Foresite Capital Management , Third Rock Ventures , SoftBank Investment Advisors, BlackRock , T Rowe Price Associates , Andreessen Horowitz , Canada Pension Plan Investment Board, ARCH Venture Partners , Casdin Capital , HOF Capital | Insitro | 15 Mar 2021 | 400.0 | Premji Invest, Orbimed Advisors , Population Health Partners , GV Management , Foresite Capital Management , Federated Hermes , Mithril Capital Management , RA Capital Management , Redmile Group , ArrowMark Partners, Polaris Partners , Adimab , Omega Fund Management , Fidelity Management & Research | Adagio Therapeutics | 19 Apr 2021 | 336.0 | SoftBank Capital, CMB International Capital Management (Shenzhen) Co., ., Morningside Venture Capital Group, IMO Ventures, ., Sequoia China Fund, Oceanpine Capital, SIG Asia Investments, L, CICC Capital Management Limited, PICC Capital Investment Management Limited, Shunwei Capital Partners, Fangyuan Capital, Parkway Capital Investors, , Mirae Asset Global Investments , Citic Capital Partners, Tencent Holdings | XtalPi | 28 Sep 2020 | 318.8 | Central Enterprise Poverty Area Industrial Investment Fund , China Merchants Securities , Tianjin Liren Investment Management, Huatai Securities | Shenzhen Huada Gene | 09 Feb 2021 | 310.3 | Casdin Capital , RA Capital Group, Vida Ventures , T Rowe Price Associates , Tybourne Capital Management (HK), ., Perceptive Advisors , BlackRock , Venrock Healthcare Capital Partners , Logos Global Management , Viking Global Investors , Wellington Management , Pfizer Venture Investments, Farallon Capital Management , Sphera Global Healthcare Master Fund, SDIC China Merchants Investment Management Co., | LianBio | 29 Oct 2020 | 310.0 |
|---|
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Senhwa Biosciences has filed an investigational new drug (IND) application seeking India’s Central Drugs Standard Control Organization’s (CDSCO) approval to initiate a Phase II trial…
Sanofi Pasteur and Translate Bio have commenced a Phase I clinical trial in the US to assess an investigational messenger ribonucleic acid (mRNA)-based vaccine candidate…
Long-awaited data of Bharat Biotech’s Covid-19 vaccine Covaxin has demonstrated a 77.8% efficacy in Phase III trials. The Subject Expert…
Histogen and its partner Amerimmune have reported top-line data from the Phase I clinical trial where emricasan was found to…
The UK Government has announced about £64m in funding to support patient-centred clinical research delivery across the country. This investment…
The University of Oxford in the UK has added ivermectin to the Platform Randomised Trial of Treatments in the Community…
GlobalData exists to help businesses decode the future to profit from faster, more informed decisions.
© Copyright Verdict Media Limited 2021
